Market closedNon-fractional

Celldex/CLDX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Celldex

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Ticker

CLDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Hampton, United States

Employees

160

Celldex Metrics

BasicAdvanced
$2.4B
Market cap
-
P/E ratio
-$2.82
EPS
1.60
Beta
-
Dividend rate
$2.4B
1.6
31.772
31.437
0.056
0.252
-15.73%
-25.39%
313.07
2.9
3
-15.72
92.76%
11.76%
4.15%
15.88%

What the Analysts think about Celldex

Analyst Ratings

Majority rating from 8 analysts.
Buy

Celldex Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-32,800.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$100K
-97.56%
Net income
-$33M
-24.25%
Profit margin
-32,800.00%
3,005.80%

Celldex Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 19.31%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.65
-$0.81
-$0.83
-$0.56
-
Expected
-$0.67
-$0.68
-$0.74
-$0.69
-$0.58
Surprise
-2.50%
19.37%
11.60%
-19.31%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Celldex stock?

Celldex (CLDX) has a market cap of $2.4B as of July 04, 2024.

What is the P/E ratio for Celldex stock?

The price to earnings (P/E) ratio for Celldex (CLDX) stock is 0 as of July 04, 2024.

Does Celldex stock pay dividends?

No, Celldex (CLDX) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Celldex dividend payment date?

Celldex (CLDX) stock does not pay dividends to its shareholders.

What is the beta indicator for Celldex?

Celldex (CLDX) has a beta rating of 1.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Celldex stock

Buy or sell Celldex stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing